Recognizing the Connection: A View into the Parallels between Asthma and Nasal Polyps

View Activity

FACULTY

John Cohn, MD
Professor
Director, Allergy & Immunology
Thomas Jefferson University Hospitals
Philadelphia, PA

Robert Naclerio, MD
Professor of Surgery
Otolaryngology and Pediatric Otolaryngology
University of Chicago
Chicago, IL

Michael Wechsler, MD, MMSc
Director, Asthma Program
Professor of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
National Jewish Health
Denver, CO

PROGRAM OVERVIEW

This enduring activity will cover the diagnosis, treatment and management of patients with asthma and the correlation between asthma and nasal polyps.

TARGET AUDIENCE

This CME initiative is designed to meet the educational needs of otolaryngologists and pulmonologists involved in the healthcare of patients with severe asthma and nasal polyps.

LEARNING OBJECTIVES

Upon completion of the program, attendees should be able to:

  • Discuss the molecular biology underlying the inflammation of asthma and nasal polyps and associated therapeutic targets
  • Reveal potential therapeutic points of collaboration between pulmonologists and otolaryngologists
  • Assess patients’ level of control, severity of disease, and exacerbation risk in the management of asthma, reveal the commonalities between asthma and nasal polyps, and discuss potential patient specific treatment options
  • Describe the clinical trial data of current and emerging antibody targeted therapies and potential biomarkers for patients with moderate-to-severe asthma and nasal polyps

ACCREDITATION AND DESIGNATION STATEMENTS

Physicians
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Purpose:
This program would be beneficial for nurses involved in the long-term treatment and management of patients with asthma.

CNE Credits:
1.0 ANCC Contact Hour(s)

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME)
Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Dr. Cohn discloses he has worked as a PI in the past year on studies sponsored by Teva, AZ, GSK and Sanofi.
Dr. Naclerio discloses he has received consulting fees from Sanofi, and is on the speakers’ bureau for Optinose. He has received salary from university of Chicago.
Dr. Wechsler discloses he is a consultant and has received honoraria from GlaxoSmithKline, Boston Scientific, Teva, Boehringer Ingelheim, Novartis, Vectura, Theravance, Sanofi/Regeneron, and AstraZeneca. He is an investigator for AstraZeneca and Sanofi/Regeneron. He has received a grant from Sanofi/Regeneron.

The independent reviewers, staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have nothing to disclose.

Staff, Planners and Managers
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
Brooke Hefele, Outcomes Coordinator for Med Learning Group has nothing to disclose.
Cathy Herbert, Medical Director, has nothing to disclose.
Melissa A Johnson, Senior Program Manager for Med Learning Group has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Submit the evaluation form to Med Learning Group.

You will receive your certification via email.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision‐making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

RELEASE DATE: April 30, 2018

EXPIRATION DATE: April 30, 2019

View Activity

Participation Statement
This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

Copyright © 2018 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.